Department of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego St, 02-957 Warsaw, Poland.
Psychopharmacology (Berl). 2012 Aug;222(4):619-32. doi: 10.1007/s00213-012-2658-4. Epub 2012 Feb 22.
Propensity for drug dependence shows great diversity that is related to intrinsic neurobiological factors. This diversity is important both for the understanding of these traits and for the development of therapies.
The goals of the study were (1) to define, using ultrasonic vocalization characteristics, inter-individual differences in rats' propensity for sensitization to amphetamine, (2) to test whether possible resistance to this effect could be overcome with repetitive treatment, and (3) to seek useful predictors of the propensity.
Rats were subject to tests meant to characterize their anxiety, pain sensitivity, and responses to novelty and natural rewards. Then they were subject to the so-called two-injection protocol of sensitization (using amphetamine) followed by 2 weeks of daily amphetamine treatment, 2-week withdrawal, and final amphetamine challenge. The development and outcome of sensitization were monitored by measuring 50-kHz vocalization.
The two-injection protocol yielded three patterns of changes in the frequency-modulated 50-kHz vocalization response to amphetamine. These patterns persisted after completion of the extended drug treatment. Rats with lower sensitivity to pain or with longer latency of their vocalization response to the first drug exposure showed an increased propensity for ultrasonic vocalization sensitization.
Vulnerability to sensitization of frequency-modulated 50-kHz vocalization response of Sprague-Dawley rats to amphetamine, which supposedly reflects rats' propensity for amphetamine dependence, shows large inter-individual diversity. Resistance to this effect, which is evident in a majority of the rats, cannot be overcome even with prolonged intermittent drug treatment under the conditions (novelty) that promote sensitization.
药物依赖倾向表现出很大的多样性,这与内在的神经生物学因素有关。这种多样性对于理解这些特征和开发治疗方法都很重要。
本研究的目的是(1)使用超声发声特征来定义大鼠对安非他命敏化倾向的个体间差异,(2)测试是否可以通过重复治疗克服对这种效应的可能抵抗,以及(3)寻求有用的倾向预测指标。
对大鼠进行了一系列测试,旨在描述它们的焦虑、疼痛敏感性、对新奇和自然奖励的反应。然后,它们接受了所谓的敏化两注射方案(使用安非他命),随后进行 2 周的每日安非他命治疗、2 周的停药和最终的安非他命挑战。通过测量 50-kHz 发声来监测敏化的发展和结果。
两注射方案导致对安非他命的频率调制 50-kHz 发声反应产生了三种变化模式。这些模式在延长药物治疗结束后仍然存在。对疼痛敏感性较低或对第一次药物暴露的发声反应潜伏期较长的大鼠,表现出更强的超声发声敏化倾向。
对安非他命诱导的 Sprague-Dawley 大鼠频率调制 50-kHz 发声反应敏化的易感性,推测反映了大鼠对安非他命依赖的倾向,表现出很大的个体间多样性。在促进敏化的条件(新奇)下,即使进行长时间的间歇性药物治疗,大多数大鼠都表现出对这种效应的抵抗,这种抵抗是无法克服的。